BTIG Research Boosts RxSight (NASDAQ:RXST) Price Target to $29.00

RxSight (NASDAQ:RXST – Get Rating) had its target price boosted by BTIG Research from $25.00 to $29.00 in a research report released on Monday morning, The Fly reports. Other analysts have also recently issued research reports about the company. Wells Fargo & Company lifted their price target on RxSight from $17.00 to $27.00 in a […]

Related Keywords

United States , ,Blackrock Inc ,Jpmorgan Chase Co ,Needham Company ,Artisan Partners Limited Partnership ,Wells Fargo Company ,Rxsight Inc ,Vanguard Group Inc ,Get Rating ,Moderate Buy ,Sight Stock Down ,Partners Limited Partnership ,Rxsight Daily ,Rxsight ,Nasdaq Rxst ,Rxst ,Medical ,Boost Price Target ,Btig Research ,